Interest of tazarotene in congenital ichthyosis;Intérêt du tazarotène dans les ichtyoses congénitales

Annales de Dermatologie et de Venereologie

Volumn 133, Issue 1, 2006, Pages 66-67

  Barbarot, S ^a   Acher Chenebaux, A ^a   Stalder, J F ^a  

^a CLINIQUE DERMATOLOGIQUE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

TAZAROTENE;

ARTICLE; CHILD; CLINICAL ARTICLE; CONGENITAL ICHTHYOSIFORM ERYTHRODERMA; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; INFANT; MALE; PRURITUS; TREATMENT OUTCOME;

EID: 32044441867     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0151-9638(06)70848-1     Document Type: Article

References (2)

1. Hofmann B, Stege H, Ruzicka T, Lehmann P. Effect of topical tazarotene in the treatment of congenital ichtyoses. Br J Dermatol 1999;141:642-6.
2. Marulli GC, Campione E, Chimenti MS, Terrinoni A, Melino G, Bianchi L. Type I lamellar ichthyosis improved by tazarotene 0.1% gel. Clin Exp Dermatol 2003;28:391-3.